Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/28/12 → 9/28/18 |
Funding
- PPD Development (Prot #GS-US-312-0117 // Prot #GS-US-312-0117)
- Gilead Sciences, Inc. (Prot #GS-US-312-0117 // Prot #GS-US-312-0117)
Prot #GS-US-312-0117: A Phase 3, Double-Blind Extension Study Evaluating the Efficacy and Safety of Two Different Dose Levels of Single-Agent GS-1101 (CAL-101) as Therapy for Patients with Previously Treated Chronic Lymphocytic Leukemia
- Ma, Shuo (PD/PI)
Project: Research project